Hettich successfully completes acquisition of Kirsch Medical
In 2023, Hettich Group experienced its most lucrative year yet in its 120-year history. For the first time, the Tuttlingen-based company, specializing in centrifuges and incubators for clinical-medical applications across three European locations, significantly surpassed the 100 million euro threshold in revenue. In addition to this outstanding organic growth, the strategic growth trajectory was further propelled by an acquisition.
The 100% acquisition of Philipp Kirsch GmbH by the Hettich Group marks a significant milestone for both entities. Based in Willstätt-Sand, Germany the Philipp Kirsch GmbH is a renowned manufacturer of high-quality cooling and freezing solutions for laboratories and healthcare, setting standards in quality and reliability since 1865.
"Our similar business philosophy and corporate culture, characterized by a high understanding of quality, long-term thinking and action, as well as the appreciation of our employees and business partners, form the foundation of this strategic partnership," stated Dr. Jochen Kopitzke, who will continue as Managing Director of Philipp Kirsch GmbH.
The synergy effects of this acquisition across the entire value chain are diverse. Given the substantial overlap in target markets between both companies, the focus is on the potential of cross-selling to streamline and expand distribution channels more efficiently. Particularly, Hettich's strong international network, comprising 6 subsidiaries and over 100 established global partners, will create opportunities significantly boosting revenue and outcomes.
"The Hettich Group will experience substantial growth, and this union provides us with the opportunity to challenge existing practices, learn together, and openly develop new perspectives," added Klaus-Günter Eberle, Managing Director of the Hettich Group. "A merger of two family-owned businesses is no longer commonplace. Yet, we see this as our future strength. We aim to synergistically evolve ‘the best of both worlds’ and proceed in a goal-oriented manner after both sides have had sufficient opportunity to get to know each other," remarked Managing Director Kristina Eberle.
The management of both companies eagerly anticipate continuing the success story and enhancing competitive prowess. The primary focus is to offer customers worldwide a broader portfolio of high-quality laboratory products and services.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
